IL-1-receptor antagonist during cephalic phase of insulin secretion in health and type 2 diabetes - The Cephalira Study
Research Project | 01.05.2020 - 31.07.2021
|
01.05.2020
- 31.07.2021
Funding
IL-1-receptor antagonist during cephalic phase of insulin secretion in health and type 2 diabetes – The Cephalira Study
Forschungsfonds (Excellent Junior Researcher) (GrantsTool), 05.2020-07.2021 (15)
CI : Donath, Marc.
Members (2)
Jonathan Mudry
Principal Investigator
